Songbing Qin

Increased vessel perfusion predicts the efficacy of immune checkpoint blockade

Xichen Zheng, Zhaoxu Fang, Xiaomei Liu et al. · Journal of Clinical Investigation · 2018 · 244 citations · Full text

Life Sciences, Immunology, Oncology +17

PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody

Gao‐Chao Lv, Xiaorong Sun, Ling Qiu et al. · Journal of Nuclear Medicine · 2019 · 176 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC

Kai Chen, Fei Zhou, Wenxiang Shen et al. · Journal of Thoracic Oncology · 2017 · 91 citations

Medicine, Oncology, Pharmacology +12

LBA39 Updated efficacy and safety data from IMbrave050: Phase III study of adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in patients (pts) with resected or ablated high-risk hepatocellular carcinoma (HCC)

Adam C. Yopp, M. Kudo, Mingkai Chen et al. · Annals of Oncology · 2024 · 85 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

CTLA4 blockade promotes vessel normalization in breast tumors <i>via</i> the accumulation of eosinophils

Xichen Zheng, Naidong Zhang, Qian Long et al. · International Journal of Cancer · 2019 · 70 citations · Full text

Life Sciences, Immunology, Oncology +17